On May 27, manufacturers were the first group of trading partners to reach the end of the Food and Drug Administration’s (FDA) phased exemption periods[1] for Drug Supply Chain Security Act (DSCSA) implementation. This was a monumental milestone for the pharmaceutical industry, marking a significant achievement after over a decade of work and investment to implement and ensure further security of the supply chain.
As the first exemption period has come to an end, the Healthcare Distribution Alliance (HDA) and its members, who are longstanding leaders in this space, have seen significant improvements in trading partner serialized transaction data exchange and the accuracy of such data each month. In anticipation of final DSCSA implementation, our organization and members have collected survey information on the industry’s progress. According to our most recent survey, distributor members report receiving over 93% of purchase order lines with accurate data from manufacturers.



















